2025.07.09 - 07.11 开闭馆时间:09:00:00 - 17:59:59
亚洲-日本 东京有明国际会展中心
主办单位:日本励展展览公司
举办周期:1年1届 会展面积:30,000平方米展商数量:800家观众数量:20,000人
距离开幕还有
198 天
暂无同场会展...
Exhibition introduction
Tokyo Biological and Pharmaceutical Exhibition 2025 (interphex), exhibition time: July 9,2025 ~ July 11, exhibition place: Japan-Tokyo-3-21-1 Ariake, Koto-ku, Tokyo 135-0063, Japan-Tokyo Youming International Convention and Exhibition Center, organizer: Li Exhibition Group (Japan) Co., LTD., holding cycle: once a year, exhibition area: 30,000 square meters, audience: 20,000 people, the number of exhibitors and brands reached 800.
Tokyo, Japan is a leading biotechnology exhibition in Asia, covering the entire biomedical industry, including drug research and development, genomics, proteomics, cell research, and regenerative medicine. It consists of four professional exhibitions, namely BioPharma Expo, INTERPHEX JAPAN, in-PHARMA JAPAN and Drink Japan.
Japan has become the world's second largest r & d investment in the biomedical industry, the world's third largest pharmaceutical and biotechnology market after the United States and China, and the second largest world in its r & d investment in the pharmaceutical and biotechnology industry. And the global biopharmaceutical industry is growing rapidly.
In recent years, with the aging trend of Japan's population, the market demand of related industries in Japan is also increasing year by year. At the same time, the Japanese government is actively carrying out the pharmaceutical market innovation policy, which needs the strong support of the international market and the introduction of new technologies and resources, especially in the research and development of new drug testing, the standardized practical application of stem cell regenerative medicine and cell therapy, and the safety technology for the detection of new drugs. This will bring unlimited business opportunities for merchants from all countries.
Scope of exhibits
Biological materials: amplification equipment, DNA extraction equipment, protein group extraction and refining, DNA analysis equipment, protein group analysis equipment, nuclear magnetic resonance, automatic workstation, automatic dispenser, cell analysis equipment, incubator, cold storage, nutrient medium, agitator, suction tube, test kit, regenerative medicine, drug development, biological materials, biological contract, pharmaceutical intermediates, cosmetic ingredients, fine chemicals, additives, excipients, plant extracts.
Instruments and equipment: analytical instruments, laboratory equipment and accessories, and chemical reagents.
Bioengineering: biological process, biochemistry, biotechnology and products, analytical methods, nanobiotechnology and products; optics and technology.
Biological information and services: Bioinformation, biotechnology services.
Medical and pharmaceutical applications: medical and pharmaceutical; biologics, biosimilars, and biobetters.
Environmental protection application: environmental protection biotechnology; agricultural application: agricultural products / planting biotechnology, animal husbandry.
Pharmaceutical excipients: pharmaceutical packaging materials, pharmaceutical excipients, pharmaceutical excipients and equipment, etc.; excipients: (antibacterial preservatives, antioxidant, capsule / encapsulation, coating agent, color, dispersion, drug delivery system, emulsification / solvent, flavor, spice, formulation development, microcapsule, ointment matrix, solvent, hardening agent, suppository base, viscosity agent, deodorant, tablet binder, tablet disder, tablet filler, tablet adhesive, tablet lubricant.moist
展会介绍
2025年日本东京生物及制药展览会( interphex),展会时间:2025年07月09日~07月11日,展会地点:日本-东京-3-21-1 Ariake, Koto-ku, Tokyo 135-0063, Japan-东京有明国际会展中心,主办方:励展集团(日本)有限公司,举办周期:一年一届,展会面积:30000平米,参展观众:20000人,参展商数量及参展品牌达到800家。
日本东京生物及制药展览会是亚洲领先的生物科技展览会,涵盖了药物研发、基因组学、蛋白质组学、细胞研究、再生医学等整个生物医药产业。由BioPharma Expo、INTERPHEX JAPAN、in-PHARMA JAPAN和Drink Japan四个专业展组成。
日本已成为生物医药行业世界第二大研发投入国,是仅次于美国和中国的世界第三大医药与生物科技市场,在医药与生物科技产业的研发领域投资规模位居全球第二。且全球生物制药产业正在迅速发展。
近年来,随着日本人口老龄化趋势的增长,该国相关产业的市场需求也在逐年递增。与此同时,日本政府正在积极开展制药市场革新政策,这一政策需要国 际市场的大力支持,引入新的技术与资源,尤其在新药品检测研发、干细胞再生医学和细胞疗法的标准化实际应用,检测新药品的安全技术等方面。这将为各国客商带来无限商机。
30,000平方米
会展面积
800+
参展商
20,000+
专业观众
50+
国家及地区